Trial Profile
A trial to study the effect of denosumab in the treatment of patients with orthostatic hypotension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Orthostatic hypotension
- Focus Therapeutic Use
- 18 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases